1. Regulation of nerve-evoked contractions of the murine vas deferens.
- Author
-
Wong PY, Fong Z, Hollywood MA, Thornbury KD, and Sergeant GP
- Subjects
- Animals, Male, Mice, Receptors, Adrenergic, alpha-1 metabolism, Electric Stimulation, Receptors, Purinergic P2X1 metabolism, Adenosine Triphosphate pharmacology, Mice, Inbred C57BL, Humans, Vas Deferens drug effects, Vas Deferens physiology, Muscle Contraction drug effects, Muscle Contraction physiology
- Abstract
Stimulation of sympathetic nerves in the vas deferens yields biphasic contractions consisting of a rapid transient component resulting from activation of P2X1 receptors by ATP and a secondary sustained component mediated by activation of α
1 -adrenoceptors by noradrenaline. Noradrenaline can also potentiate the ATP-dependent contractions of the vas deferens, but the mechanisms underlying this effect are unclear. The purpose of the present study was to investigate the mechanisms underlying potentiation of transient contractions of the vas deferens induced by activation of α1 -adrenoceptors. Contractions of the mouse vas deferens were induced by electric field stimulation (EFS). Delivery of brief (1s duration) pulses (4 Hz) yielded transient contractions that were inhibited tetrodotoxin (100 nM) and guanethidine (10 µM). α,β-meATP (10 µM), a P2X1R desensitising agent, reduced the amplitude of these responses by 65% and prazosin (100 nM), an α1 -adrenoceptor antagonist, decreased mean contraction amplitude by 69%. Stimulation of α1 -adrenoceptors with phenylephrine (3 µM) enhanced EFS and ATP-induced contractions and these effects were mimicked by the phorbol ester PDBu (1 µM), which activates PKC. The PKC inhibitor GF109203X (1 µM) prevented the stimulatory effects of PDBu on ATP-induced contractions of the vas deferens but only reduced the stimulatory effects of phenylephrine by 40%. PDBu increased the amplitude of ATP-induced currents recorded from freshly isolated vas deferens myocytes and HEK-293 cells expressing human P2X1Rs by 93%. This study indicates that: (1) potentiation of ATP-evoked contractions of the mouse vas deferens by α1 -adrenoceptor activation were not fully blocked by the PKC inhibitor GF109203X and (2) that the stimulatory effect of PKC on ATP-induced contractions of the vas deferens is associated with enhanced P2X1R currents in vas deferens myocytes., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF